Vanda Pharmaceuticals Inc (VNDA) insider trading
Every open-market stock purchase and sale by Vanda Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.8M over the last 12 months (6 sales). No open-market buys.
- Last insider buy: Mihael Hristos Polymeropoulos (CEO), $41.5K, 14 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.8M (6 sales). Last close $5.94 on Jun 7, 2026.
Recent VNDA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | Anne Sempowski Ward (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Phaedra Chrousos (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Richard W Dugan (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Charles Cliff Duncan (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Tage Honore (Insider) | Bought (not open market) | — |
| Jun 4, 2026 | Daniel Patrick McGuire (VP) | Bought (not open market) | — |
| Jun 4, 2026 | Stephen Ray Mitchell (Insider) | Bought (not open market) | — |
| May 18, 2026 | Stephen Ray Mitchell (Insider) | Sold (not open market) | — |
| Apr 22, 2026 | Charles Cliff Duncan (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Mihael Hristos Polymeropoulos (CEO) | Sold | $1.3M |
| Mar 2, 2026 | Kevin Patrick Moran (CFO) | Sold | $351K |
| Mar 2, 2026 | Timothy Williams (VP) | Sold | $351K |
| Mar 2, 2026 | Gunther Birznieks (VP) | Sold | $351K |
| Mar 2, 2026 | Joakim Wijkstrom (C-suite exec) | Sold | $255K |
| Feb 23, 2026 | Tage Honore (Insider) | Sold | $241K |
| Feb 18, 2026 | Timothy Williams (VP) | Bought (not open market) | — |
| Feb 18, 2026 | Joakim Wijkstrom (C-suite exec) | Bought (not open market) | — |
| Feb 18, 2026 | Kevin Patrick Moran (CFO) | Bought (not open market) | — |
| Feb 18, 2026 | Mihael Hristos Polymeropoulos (CEO) | Bought (not open market) | — |
| Feb 18, 2026 | Gunther Birznieks (VP) | Bought (not open market) | — |
Who's trading VNDA
- Phaedra Chrousos, Insider: other filings, last Jun 4, 2026
- Richard W Dugan, Insider: other filings, last Jun 4, 2026
- Anne Sempowski Ward, Insider: other filings, last Jun 4, 2026
- Charles Cliff Duncan, Insider: other filings, last Jun 4, 2026
- Tage Honore, Insider: sold $241K (1 sale), last Jun 4, 2026
- Daniel Patrick McGuire, VP: other filings, last Jun 4, 2026
- Stephen Ray Mitchell, Insider: other filings, last Jun 4, 2026
- Timothy Williams, VP: sold $351K (1 sale), last Mar 2, 2026
- Kevin Patrick Moran, CFO: sold $351K (1 sale), last Mar 2, 2026
- Mihael Hristos Polymeropoulos, CEO: sold $1.3M (1 sale), last Mar 2, 2026
- Joakim Wijkstrom, C-suite exec: sold $255K (1 sale), last Mar 2, 2026
- Gunther Birznieks, VP: sold $351K (1 sale), last Mar 2, 2026
Get free alerts when an insider at Vanda Pharmaceuticals Inc files a new trade →